Protease activated receptor 2 (PAR2) expression in the myeloid compartment impacts osteoclastogenesis

John Lockhart, Sarah McGrath, Leif Hultin, Carl Goodyear

Research output: Contribution to journalMeeting Abstract

37 Citations (Scopus)

Abstract

Introduction: Protease activated receptor 2 (PAR2) is a G protein coupled receptor responsive to serine proteases, which plays a key role in inflammation and pain reception. Rheumatoid arthritis (RA) patients have up-regulated surface expression of PAR2 in circulating monocytes which correlates with disease activity. We have previously demonstrated that Par2 -/- mice are protected from inflammation, bone erosion, and cartilage destruction in a Freund’s Complete Adjuvant (FCA) induced arthritis model. However, it is unclear how PAR2 affects the composition of the myeloid compartment and osteoclastogenesis.

Objectives: The aim of this study was to evaluate the impact of loss of PAR2 on the myeloid compartment and osteoclastogenesis.

Methods: Bone marrow (BM) from 6–10 week old Par2 -/- and control C57BL/6 mice was cultured in pro-osteoclastogenic media for 5 days and the generated mature osteoclasts, tartrate-resistant acid phosphatase positive (TRAP) multinucleated cells, were counted. The resorption potential of these cells was assessed using osteolysis plates and the total osteo-resorption quantified after 7–14 days of culture. BM was also collected for flow cytometric analysis of the haematopoietic cellular composition (with the following markers: CD3, B220, CD11b, Ly6C, Ly6G, CD115, and CD117) and assessed for osteoclast precursors.

Results: In vitro osteoclastogenesis revealed an increase in numbers of mature osteoclasts from Par2 -/- BM compared to WT, corresponding with increased levels of resorption. Flow cytometry of BM from both WT and Par2 -/- mice showed 3 distinct monocyte populations defined by the cell surface expression levels of CD11b and Ly6C. The overall ratio of these populations was not altered in Par2 -/- animals.

Conclusions: BM from Par2 -/- mice has increased osteoclastogenic potential and overall resorptive activity. We propose that this is not due to differences in bone marrow residing osteoclast pre-cursor numbers. This study indicates a potential role for PAR2 in osteoclast differentiation and bone remodelling.
Original languageEnglish
Article numberP018
Pages (from-to)A21
Number of pages1
JournalAnnals of the Rheumatic Diseases
Volume77
Issue numberSupplement 1
DOIs
Publication statusPublished - 21 Feb 2018
EventEuropean Workshop for Rheumatology Research - Geneva, Switzerland
Duration: 22 Feb 201824 Feb 2018
Conference number: 38

Keywords

  • PAR2
  • Osteoarthritis
  • Medical Research Scotland
  • Osteoclasts
  • myeloid

Fingerprint Dive into the research topics of 'Protease activated receptor 2 (PAR2) expression in the myeloid compartment impacts osteoclastogenesis'. Together they form a unique fingerprint.

  • Press / Media

    £1.2m grant for Osteoarthritis research

    John Lockhart

    1/01/13

    1 item of Media coverage

    Press/Media: Research

    £1.2m to research new treatments for Osteoarthritis

    John Lockhart

    1/01/13

    1 item of Media coverage

    Press/Media: Research

    Cite this